-->
Vacuum blood collection tube market was valued at US$ 3.24 billion in 2024 and is projected to hit the market valuation of US$ 4.40 billion by 2033 at a CAGR of 3.45% during the forecast period 2025–2033.
Automated immunoassay analyzers market was valued at US$ 23.12 billion in 2024 and is projected to hit the market valuation of US$ 74.59 billion by 2033 at a CAGR of 13.90% during the forecast period 2025–2033.
Japan point-of-care testing market was valued at US$ 2,361.59 million in 2024 and is projected to hit the market valuation of US$ 4,557.56 million by 2033 at a CAGR of 7.91% during the forecast period 2025–2033.
Pulsed electromagnetic field therapy devices market was valued at US$ 755.82 million in 2024 and is projected to hit the market valuation of US$ 1,194.70 million by 2033 at a CAGR of 5.89% during the forecast period 2025–2033.
The traumatic brain injury (TBI) market is expected to witness significant growth, with revenues projected to increase from USD 2.5 billion in 2024 to USD 4.7 billion by 2033, registering a strong CAGR of 7.2% during the forecast period.
Complementary and alternative medicine market was valued at US$ 193.36 billion in 2024 and is projected to hit the market valuation of US$ 1,282.70 billion by 2033 at a CAGR of 23.56% during the forecast period 2025–2033.
Point-of-care testing market was valued at US$ 46.48 billion in 2024 and is projected to hit the market valuation of US$ 85.55 billion by 2033 at a CAGR of 7.33% during the forecast period 2025–2033.
The glioblastoma multiforme treatment market is projected to grow from USD 3.0 billion in 2024 to USD 6.1 billion by 2033, registering a compound annual growth rate (CAGR) of 8.5% during the forecast period.
Hernia repair devices market was valued at US$ 4.69 billion in 2024 and is projected to hit the market valuation of US$ 6.57 billion by 2033 at a CAGR of 4.32% during the forecast period 2025–2033.
Amyotrophic lateral sclerosis treatment market is projected to grow from USD 724.5 million in 2024 to USD 1,234.5 million by 2033, expanding at a compound annual growth rate (CAGR) of 6.1% during the forecast period.